9:00am - 5:00pm

Our Opening Hours Mon. - Fri.

1.800.799.2234

Call Us For Free Consultation

Facebook

Twitter

Search
 

Survival of Peritoneal Mesothelioma After Cytoreductive Surgery and Hyperthermic Intra-peritoneal Chemotherapy (HIPEC)

Top West Virginia Mesothelioma Lawyer | Law Firm | Attorney | GPW > Survival of Peritoneal Mesothelioma After Cytoreductive Surgery and Hyperthermic Intra-peritoneal Chemotherapy (HIPEC)

Survival of Peritoneal Mesothelioma After Cytoreductive Surgery and Hyperthermic Intra-peritoneal Chemotherapy (HIPEC)

Estimated reading time: < 1 min

Condition: Peritoneal Mesotheliomas

Estimated Enrollment: 19

Gender: All

Min Age:

Age Group: Child, Adult

Current Status: Completed

Study Results: No Results Available

Outcome Measures: Overall survival,  Disease-Free survival,  ,

Interventions: Cytoreductive surgery and HIPEC,

Phase:

Study Type: Observational

Study Design: Observational Model: Case-Crossover, Time Perspective: Retrospective, ,

Primary Completion Date: March 2013

Completion Date: March 2013

Last  Posted Date: March 18, 2013

Location: Maisonneuve Rosemont Hospital, Montréal, Quebec, Canada

Website Link: https://ClinicalTrials.gov/show/NCT01812148

Was this article helpful?
Dislike 0